Saia John G. sold $1.3M of GH
Saia John G. (Chief Legal Officer) sold 10,000 shares of Guardant Health, Inc. (GH) at an average of $125.08 ($125.08–$126.08, $1.25M total) across 2 trades on 2026-05-27 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the CFO’s open-market sale details (shares, price range, total value) executed under a pre-arranged 10b5-1 plan.
Market read
This provides incremental transparency on insider selling, but it is not a fundamental catalyst by itself.
What to watch
The filing does not state motivations; traders should compare with prior insider activity frequency and whether sales cluster around specific events (earnings, trial readouts).
Background
The article is an SEC Form 4 insider transaction disclosure for Guardant Health, Inc.
Ticker impact
Guardant Health disclosed an insider Form 4 showing CFO John G. Saia sold about 10,000 shares in open-market trades under a 10b5-1 plan.
Likely minimal impact on the stock, unless investors extrapolate unusual selling beyond the plan.
The filing specifies a Rule 10b5-1 pre-arranged plan and an open-market sale; the disclosed transaction is not tied to a new operational or regulatory event.
Market effects
No clear sector read-through; this is company-specific insider activity without new guidance or trial/regulatory updates.
None indicated.
None indicated.
Counterpoint
Insider sales can be interpreted as diversification rather than bearish information, especially when executed under a 10b5-1 plan.
Key entities
- issuerGuardant Health, Inc.
Company whose insider transaction was disclosed on Form 4.
- insiderJohn G. Saia
Chief Legal Officer who sold shares in open-market trades under a 10b5-1 plan.
